Oncolytics Biotech Inc. (ONCY) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Oncolytics Biotech Inc. (ONCY) closed at USD 0.54 on 2026-10-14, a change of -55.7 % over the past year, with a market capitalization of USD 71.8M.

Oncolytics Biotech Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Oncolytics Biotech Inc. key figures

Previous close

USD 0.54 (2026-10-14)

1-year change

-55.7 %

Market cap

USD 71.8M

Enterprise value

USD 66.16M

P/E ratio (trailing)

-1.40

P/E ratio (forward)

-2.78

EPS (trailing)

-0.39

EPS (forward)

-0.20

PEG ratio

n/a

Price to book

-11.18

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

6.69

Employees

29

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Oncolytics Biotech Inc.

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (“GI”) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Oncolytics Biotech Inc. and compare it with other stocks.